Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial

Erstveröffentlichung

2019

Authors

Weller, Johannes

Tzaridis, Theophilos

Mack, Frederic

Steinbach, Joachim Peter

Schlegel, Uwe

et al.

Wissenschaftlicher Artikel

Published in

Lancet Oncology ; 20 (2019), 10. - S. 1444-1453. - ISSN 1470-2045. - eISSN 1474-5488

Link to publication

https://dx.doi.org/10.1016/S1470-2045(19)30502-9

Institutions

UKU. Klinik für Innere Medizin III

Subject headings

[Free subject headings]: MINI-MENTAL-STATE | RADIOTHERAPY | BEVACIZUMAB | QUESTIONNAIRE | COMBINATION | VALIDATION
[DDC subject group]: DDC 610 / Medicine & health

---

Metadata

Show full item record